Atbf1 Regulates Pubertal Mammary Gland Development Likely by Inhibiting the Pro-Proliferative Function of Estrogen-ER Signaling

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Li, Mei ^a,b   Fu, Xiaoying ^b   Ma, Gui ^a   Sun, Xiaodong ^b   Dong, Xueyuan ^b   Nagy, Tamas ^c   Xing, Changsheng ^b   Li, Jie ^b   Dong, Jin Tang ^a,b  

^a NANKAI UNIVERSITY   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; CYTOKERATIN 5; ESTROGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN;

ANIMAL TISSUE; ARTICLE; AT MOTIF BINDING FACTOR 1 GENE; BASAL CELL; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LACTATION; MOUSE; NONHUMAN; PREGNANCY; PUBERTY; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; BASE SEQUENCE; BREAST; CELL LINE, TUMOR; DNA PRIMERS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; PUBERTY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84871240614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051283     Document Type: Article

References (70)

1. Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T, (1991) A human alpha-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol Cell Biol 11: 6041-6049.
2. Yasuda H, Mizuno A, Tamaoki T, Morinaga T, (1994) ATBF1, a multiple-homeodomain zinc finger protein, selectively down-regulates AT-rich elements of the human alpha-fetoprotein gene. Mol Cell Biol 14: 1395-1401.
3. Sun X, Frierson HF, Chen C, Li C, Ran Q, et al. (2005) Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 37: 407-412.
4. Sun X, Zhou Y, Otto KB, Wang M, Chen C, et al. (2007) Infrequent mutation of ATBF1 in human breast cancer. J Cancer Res Clin Oncol 133: 103-105.
5. Cleton-Jansen AM, van Eijk R, Lombaerts M, Schmidt MK, Van't Veer LJ, et al. (2008) ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. BMC Cancer 8: 105.
6. Kai K, Zhang Z, Yamashita H, Yamamoto Y, Miura Y, et al. (2008) Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer. BMC Cancer 8: 262.
7. Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, et al. (2005) ATBF1-A messenger RNA expression is correlated with better prognosis in breast cancer. Clin Cancer Res 11: 193-198.
8. Kataoka H, Bonnefin P, Vieyra D, Feng X, Hara Y, et al. (2003) ING1 represses transcription by direct DNA binding and through effects on p53. Cancer Res 63: 5785-5792.
9. Miura Y, Kataoka H, Joh T, Tada T, Asai K, et al. (2004) Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter. Microbiol Immunol 48: 137-145.
10. Nojiri S, Joh T, Miura Y, Sakata N, Nomura T, et al. (2004) ATBF1 enhances the suppression of STAT3 signaling by interaction with PIAS3. Biochem Biophys Res Commun 314: 97-103.
11. Ido A, Miura Y, Tamaoki T, (1994) Activation of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal differentiation of murine embryonal carcinoma cells. Dev Biol 163: 184-187.
12. Ishii Y, Kawaguchi M, Takagawa K, Oya T, Nogami S, et al. (2003) ATBF1-A protein, but not ATBF1-B, is preferentially expressed in developing rat brain. J Comp Neurol 465: 57-71.
13. Jung CG, Kim HJ, Kawaguchi M, Khanna KK, Hida H, et al. (2005) Homeotic factor ATBF1 induces the cell cycle arrest associated with neuronal differentiation. Development 132: 5137-5145.
14. Nogami S, Ishii Y, Kawaguchi M, Sakata N, Oya T, et al. (2005) ZFH4 protein is expressed in many neurons of developing rat brain. J Comp Neurol 482: 33-49.
15. Kataoka H, Joh T, Miura Y, Tamaoki T, Senoo K, et al. (2000) AT motif binding factor 1-A (ATBF1-A) negatively regulates transcription of the aminopeptidase N gene in the crypt-villus axis of small intestine. Biochem Biophys Res Commun 267: 91-95.
16. Qi Y, Ranish JA, Zhu X, Krones A, Zhang J, et al. (2008) Atbf1 is required for the Pit1 gene early activation. Proc Natl Acad Sci U S A 105: 2481-2486.
17. Roylance R, Gorman P, Papior T, Wan YL, Ives M, et al. (2006) A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH. Oncogene 25: 6544-6553.
18. Dong XY, Fu X, Fan S, Guo P, Su D, et al. (2012) Oestrogen causes ATBF1 protein degradation through the oestrogen-responsive E3 ubiquitin ligase EFP. Biochem J 444: 581-590.
19. Dong XY, Guo P, Sun X, Li Q, Dong JT, (2011) Estrogen up-regulates ATBF1 transcription but causes its protein degradation in estrogen receptor-alpha-positive breast cancer cells. J Biol Chem 286: 13879-13890.
20. Dong XY, Sun X, Guo P, Li Q, Sasahara M, et al. (2010) ATBF1 inhibits estrogen receptor (ER) function by selectively competing with AIB1 for binding to the ER in ER-positive breast cancer cells. J Biol Chem 285: 32801-32809.
21. Brisken C, (2002) Hormonal control of alveolar development and its implications for breast carcinogenesis. J Mammary Gland Biol Neoplasia 7: 39-48.
22. Siegel PM, Muller WJ, (2010) Transcription factor regulatory networks in mammary epithelial development and tumorigenesis. Oncogene 29: 2753-2759.
23. Brisken C, O'Malley B, (2010) Hormone action in the mammary gland. Cold Spring Harb Perspect Biol 2: a003178.
24. Hennighausen L, Robinson GW, (2005) Information networks in the mammary gland. Nat Rev Mol Cell Biol 6: 715-725.
25. Debnath J, Muthuswamy SK, Brugge JS, (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30: 256-268.
26. Sun X, Fu X, Li J, Xing C, Martin DW, et al. (2012) Heterozygous deletion of Atbf1 by the Cre-loxP system in mice causes preweaning mortality. Genesis.
27. Nagy T, Wei H, Shen TL, Peng X, Liang CC, et al. (2007) Mammary epithelial-specific deletion of the focal adhesion kinase gene leads to severe lobulo-alveolar hypoplasia and secretory immaturity of the murine mammary gland. J Biol Chem 282: 31766-31776.
28. LaRocca J, Pietruska J, Hixon M, (2011) Akt1 is essential for postnatal mammary gland development, function, and the expression of Btn1a1. PLoS ONE 6: e24432.
29. Marshall AM, Pai VP, Sartor MA, Horseman ND, (2009) In vitro multipotent differentiation and barrier function of a human mammary epithelium. Cell Tissue Res 335: 383-395.
30. Coppock HA, Gilham DE, Howell A, Clarke RB, (2007) Cyclin-dependent kinase inhibitors and basement membrane interact to regulate breast epithelial cell differentiation and acinar morphogenesis. Cell Prolif 40: 721-740.
31. Ciarloni L, Mallepell S, Brisken C, (2007) Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci U S A 104: 5455-5460.
32. McBryan J, Howlin J, Napoletano S, Martin F, (2008) Amphiregulin: role in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 13: 159-169.
33. Sternlicht MD, Sunnarborg SW, (2008) The ADAM17-amphiregulin-EGFR axis in mammary development and cancer. J Mammary Gland Biol Neoplasia 13: 181-194.
34. Ruan W, Kleinberg DL, (1999) Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140: 5075-5081.
35. Louderbough JM, Brown JA, Nagle RB, Schroeder JA, (2011) CD44 Promotes Epithelial Mammary Gland Development and Exhibits Altered Localization during Cancer Progression. Genes Cancer 2: 771-781.
36. Li Y, Rosen JM, (2005) Stem/progenitor cells in mouse mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 10: 17-24.
37. Taddei I, Deugnier MA, Faraldo MM, Petit V, Bouvard D, et al. (2008) Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 10: 716-722.
38. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, et al. (2011) Distinct stem cells contribute to mammary gland development and maintenance. Nature 479: 189-193.
39. Barsky SH, (2003) Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Pathol 74: 113-122.
40. Barsky SH, Karlin NJ, (2005) Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia 10: 249-260.
41. Li W, Ferguson BJ, Khaled WT, Tevendale M, Stingl J, et al. (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A 106: 4725-4730.
42. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z, (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127: 1041-1055.
43. Bocker W, Moll R, Poremba C, Holland R, Van Diest PJ, et al. (2002) Common adult stem cells in the human breast give rise to glandular and myoepithelial cell lineages: a new cell biological concept. Lab Invest 82: 737-746.
44. Russo J, Ao X, Grill C, Russo IH, (1999) Pattern of distribution of cells positive for estrogen receptor alpha and progesterone receptor in relation to proliferating cells in the mammary gland. Breast Cancer Res Treat 53: 217-227.
45. Stossi F, Madak-Erdogan Z, Katzenellenbogen BS, (2009) Estrogen receptor alpha represses transcription of early target genes via p300 and CtBP1. Mol Cell Biol 29: 1749-1759.
46. Cunha GR, Young P, Hom YK, Cooke PS, Taylor JA, et al. (1997) Elucidation of a role for stromal steroid hormone receptors in mammary gland growth and development using tissue recombinants. J Mammary Gland Biol Neoplasia 2: 393-402.
47. Feng Y, Manka D, Wagner KU, Khan SA, (2007) Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice. Proc Natl Acad Sci U S A 104: 14718-14723.
48. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, et al. (2000) Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 141: 2982-2994.
49. Huh JI, Qiu TH, Chandramouli GV, Charles R, Wiench M, et al. (2007) 2-methoxyestradiol induces mammary gland differentiation through amphiregulin-epithelial growth factor receptor-mediated signaling: molecular distinctions from the mammary gland of pregnant mice. Endocrinology 148: 1266-1277.
50. Michels KM, Lee WH, Seltzer A, Saavedra JM, Bondy CA, (1993) Up-regulation of pituitary [125I]insulin-like growth factor-I (IGF-I) binding and IGF binding protein-2 and IGF-I gene expression by estrogen. Endocrinology 132: 23-29.
51. Dubik D, Dembinski TC, Shiu RP, (1987) Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res 47: 6517-6521.
52. Smith CL, (1998) Cross-talk between peptide growth factor and estrogen receptor signaling pathways. Biol Reprod 58: 627-632.
53. Fagan DH, Yee D, (2008) Crosstalk between IGF1R and estrogen receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 13: 423-429.
54. Hall JM, Couse JF, Korach KS, (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872.
55. Murphy LJ, Ghahary A, (1990) Uterine insulin-like growth factor-1: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr Rev 11: 443-453.
56. Rowzee AM, Lazzarino DA, Rota L, Sun Z, Wood TL, (2008) IGF ligand and receptor regulation of mammary development. J Mammary Gland Biol Neoplasia 13: 361-370.
57. Liao DJ, Dickson RB, (2000) c-Myc in breast cancer. Endocr Relat Cancer 7: 143-164.
58. Clarke RB, Howell A, Potten CS, Anderson E, (1997) Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 57: 4987-4991.
59. Ido A, Miura Y, Tamaoki T, (1994) Activation of ATBF1, a multiple-homeodomain zinc-finger gene, during neuronal differentiation of murine embryonal carcinoma cells. Dev Biol 163: 184-187.
60. Miura Y, Tam T, Ido A, Morinaga T, Miki T, et al. (1995) Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J Biol Chem 270: 26840-26848.
61. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, et al. (2009) Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-913.
62. Shao ZM, Nguyen M, Alpaugh ML, O'Connell JT, Barsky SH, (1998) The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. Exp Cell Res 241: 394-403.
63. Jones JL, Shaw JA, Pringle JH, Walker RA, (2003) Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol 201: 562-572.
64. Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, et al. (2002) Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 115: 39-50.
65. Runswick SK, O'Hare MJ, Jones L, Streuli CH, Garrod DR, (2001) Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat Cell Biol 3: 823-830.
66. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, et al. (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9: 201-209.
67. Usary J, Llaca V, Karaca G, Presswala S, Karaca M, et al. (2004) Mutation of GATA3 in human breast tumors. Oncogene 23: 7669-7678.
68. Kurley SJ, Bierie B, Carnahan RH, Lobdell NA, Davis MA, et al. (2012) p120-catenin is essential for terminal end bud function and mammary morphogenesis. Development 139: 1754-1764.
69. Jones LP, Tilli MT, Assefnia S, Torre K, Halama ED, et al. (2008) Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Oncogene 27: 794-802.
70. Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, et al. (2002) Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129: 4159-4170.